As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...
Shares of Novo Nordisk and Eli Lilly gain following study results that show GLP-1 drugs cut the risk of heart and kidney ...
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...
Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a ...
ImmunoPrecise Antibodies (IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance ...
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but ...
Ozempic, Wegovy, Mounjaro, and Zepbound are all classified as GLP-1 drugs. These medications, which are taken by injection, work by simulating naturally produced hormones that curb appetite and ...
The Company’s GLP-1-like alternatives are currently being evaluated for potential transdermal delivery as non-invasive alternatives to injections. These novel constructs represent the Company's ...
The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...
NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names ... to treat sleep apnea FDA says shortage of GLP-1 drug tirzepatide is over Merck reaches weight-loss drug ...